Table 2 Antitumor activity

Objective response rate, no. (%)

17 (68)

 95% CI

0.48–0.88

Disease control rate, no. (%)

23 (92)

 95% CI

0.81–1.03

Best overall response, no. (%)

 Complete response

3 (12)

 Partial response

14 (56)

 Stable disease

6 (24)

 Progressive disease

1 (4)

 Unevaluable

1 (4)